Organization
4D Molecular Therapeutics
7 clinical trials
Clinical trial
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic FibrosisStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
A Phase 1/2 Dose-Escalation and Randomized, Controlled, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults With Neovascular (Wet) Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-125 in Males With X-linked Retinitis Pigmentosa (XLRP) Caused by Mutations in the RPGR GeneStatus: Active (not recruiting), Estimated PCD: 2026-06-01
Clinical trial
An Open-Label, Phase 1/2a Trial of Gene Therapy 4D-310 in Adults With Fabry Disease and Cardiac InvolvementStatus: Active (not recruiting), Estimated PCD: 2026-01-01
Clinical trial
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry DiseaseStatus: Active (not recruiting), Estimated PCD: 2026-01-01
Clinical trial
Phase 1 Open-Label, Dose-Escalation Study of the Safety, Tolerability and Preliminary Efficacy of Intravitreal 4D-110 in Patients With ChoroideremiaStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A Phase 2 Randomized, Active-Controlled, Double-masked Trial of Intravitreal 4D-150 Gene Therapy in Adults With Diabetic Macular Edema (SPECTRA)Status: Recruiting, Estimated PCD: 2028-02-29